MEETINGS - Two-day seminars on Good Monitoring Practices (Belgium) April 2002 and (US) August 2002:
This article was originally published in Clinica
Executive Summary
The Clinical Device Group is hosting a series of two-day seminars on Good Monitoring Practices. The first scheduled date is April 11-12 2002 at the Hotel Leopold Brussels, Brussels, Belgium. The second scheduled date is on August 22-23 2002 at the Four Points Sheraton Hotel, Boston, Massachusetts. The seminars aim to teach proven methods of managing sites to ensure the most accurate data. They will address ethical and practical standards, consent writing in the US and Europe, review committee relations and other aspects of successful monitoring practices. Further details from Maria Sikirica on tel: +1 773 489 5706; fax: +1 773 489 5982; email: [email protected] www.clinicaldesign.com
You may also be interested in...
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.